ASLAN Pharmaceuticals, a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced financial results for the second quarter ended June 30, 2021, and provided an update on recent corporate activities.
August 6, 2021
· 10 min read
